Literature DB >> 28162799

Cannabidiol: Swinging the Marijuana Pendulum From 'Weed' to Medication to Treat the Opioid Epidemic.

Yasmin L Hurd1.   

Abstract

Epidemics require a paradigm shift in thinking about all possible solutions. The rapidly changing sociopolitical marijuana landscape provides a foundation for the therapeutic development of medicinal cannabidiol to address the current opioid abuse crisis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28162799     DOI： 10.1016/j.tins.2016.12.006

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


  23 in total

1.  Hemp & Cannabidiol: What is a Medicine?

Authors:  R L Hilderbrand
Journal:  Mo Med       Date:  2018 Jul-Aug

2.  High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Authors:  Maria Eugenia Socías; Evan Wood; Stephanie Lake; Seonaid Nolan; Nadia Fairbairn; Kanna Hayashi; Hennady P Shulha; Seagle Liu; Thomas Kerr; M-J Milloy
Journal:  Addiction       Date:  2018-09-20       Impact factor: 6.526

3.  Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018.

Authors:  Hudson Reddon; Kora DeBeck; M Eugenia Socias; Stephanie Lake; Huiru Dong; Mohammad Karamouzian; Kanna Hayashi; Thomas Kerr; M-J Milloy
Journal:  Am J Public Health       Date:  2020-08-20       Impact factor: 9.308

4.  Dispensary cannabidiol marijuana and first-episode mania.

Authors:  Zahinoor Ismail
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

Review 5.  Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data.

Authors:  Kent E Hutchison; Sarah L Hagerty; Jeffrey Galinkin; Angela D Bryan; L Cinnamon Bidwell
Journal:  Cannabis Cannabinoid Res       Date:  2019-09-23

6.  Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Authors:  Gustavo Gonzalez-Cuevas; Remi Martin-Fardon; Tony M Kerr; David G Stouffer; Loren H Parsons; Dana C Hammell; Stan L Banks; Audra L Stinchcomb; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2018-03-22       Impact factor: 7.853

Review 7.  Cannabidiol and substance use disorder: Dream or reality.

Authors:  Saeideh Karimi-Haghighi; Yasaman Razavi; Daniela Iezzi; Andrew F Scheyer; Olivier Manzoni; Abbas Haghparast
Journal:  Neuropharmacology       Date:  2022-01-13       Impact factor: 5.273

Review 8.  Pharmacological challenge studies with acute psychosocial stress.

Authors:  Kathryne Van Hedger; Anya K Bershad; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2017-08-22       Impact factor: 4.905

9.  Frequent Cannabis Use Is Negatively Associated with Frequency of Injection Drug Use Among People Who Inject Drugs in a Canadian Setting.

Authors:  Hudson Reddon; Kora DeBeck; Maria-Eugenia Socias; Stephanie Lake; Huiru Dong; Kanna Hayashi; Michael-John Milloy
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-21

10.  Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.

Authors:  Sinikka L Kvamme; Michael M Pedersen; Kristine Rømer Thomsen; Birgitte Thylstrup
Journal:  Harm Reduct J       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.